Innovation and Preserved Ejection Fraction

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

DAIC

MAY 6, 2024

We are committed to protecting the future commercial value of our innovative PH-HFpEF treatment,” said Chris Giordano , President & Chief Executive Officer of Tenax Therapeutics. Getty Images milla1cf Mon, 05/06/2024 - 10:48 May 6, 2024 — Tenax Therapeutics, Inc. ,

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Pulmonary Hypertension

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research in Chronic Kidney Disease at ACC.25

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Kidney Disease Research

Mouse study finds increasing cardiac ketones may help treat heart failure

Medical Xpress - Cardiology

JULY 24, 2024

Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF) allowed their hearts to utilize more ketones and produce more energy, according to preliminary research presented today at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2024.

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Innovation Research

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT‐HFpEF): Rationale and design

European Journal of Heart Failure

DECEMBER 19, 2024

BNP, B-type natriuretic peptide; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular filtration rate; EP, endpoint; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide; SwedeHF, Swedish Heart Failure Registry; US, United States.

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Atrial Fibrillation Outpatient

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Research Academic

Developing a contemporary community clinic for patients with heart failure with preserved ejection fraction within the current National Health Service model

Open Heart

NOVEMBER 4, 2022

We; therefore, evaluated the efficacy of an existing dedicated HFpEF clinic to find innovative ways to design a more comprehensive model tailored to the modern era of HFpEF. Methods A single-centre retrospective analysis of 202 HFpEF outpatients was performed over 12 months before the COVID-19 pandemic.

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure COVID-19 Outpatient

American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24

DAIC

APRIL 3, 2024

Featured topics will include in-depth sessions covering non-statin lipid lowering therapies, heart failure with preserved ejection fraction, viability, imaging modalities for the assessment of coronary artery disease, and antiplatelet therapy after coronary stenting. 24 news here.

Education

Education Preserved Ejection Fraction Coronary Artery Disease Cardio Oncology

Basic Science of Cardiac Contractility Modulation Therapy: Molecular and Electrophysiological Mechanisms

HeartRhythm

SEPTEMBER 25, 2023

In heart failure with reduced ejection fraction and heart failure with preserved ejection fraction, profound cellular and molecular changes have recently been documented in the failing myocardium.These changes include altered calcium handling and metabolic efficiency of the cardiac myocyte, reactivation of the fetal gene program, changes in the electrophysiological (..)

Preserved Ejection Fraction

Preserved Ejection Fraction Electrophysiology Heart Failure Document

Corvia atrial shunt system: Mean LA pressure reduction device in HFpEF

Dr. S. Venkatesan MD

APRIL 18, 2024

May be, it will come soon in the innovative lanes of cardiology. Shah, author of Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. Probably in the thin membranous area. Interview with Sanjiv J. Hosted by James E.

Preserved Ejection Fraction

Preserved Ejection Fraction Pulmonary Congenital Heart Disease VSD

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

FEBRUARY 29, 2024

ET Murphy Ballroom 4 Comparison of an "Inclisiran First" Strategy with Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial Targeting Weight Loss to Personalize the Prevention of Type 2 Diabetes Once-weekly Semaglutide in Patients with Heart Failure With Preserved Ejection Fraction, (..)

Aortic valve

Aortic valve Myocardial Infarction Aortic Blood Pressure

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection.

CME

CME Obesity Heart Failure Biomarkers

Heartfelt innovations: advances in cardiorenal care

The British Journal of Cardiology

JANUARY 14, 2025

We report from the 19 th Annual Scientific Meeting of the Cardiorenal Forum held in London on 4 th October 2024, which served as a dynamic platform for experts in cardiology, diabetes, and renal medicine to converge and exchange the latest insights on managing heart and kidney failure.

Innovation

Innovation Diabetes Preserved Ejection Fraction Outcomes

What Cardiometabolic Clinicians Can Be Thankful For This Year

Cardiometabolic Health Congress

NOVEMBER 22, 2024

From breakthrough medications to innovative technologies, there is a lot for cardiometabolic clinicians professionals to celebrate. Clinicians now have access to new medications, innovative technologies, and refined clinical guidelines that empower them to provide more personalized, effective care to their patients.

Blood Pressure

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease

Cardiovascular Update

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research in Chronic Kidney Disease at ACC.25

Mouse study finds increasing cardiac ketones may help treat heart failure

Webinars

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT‐HFpEF): Rationale and design

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research

Developing a contemporary community clinic for patients with heart failure with preserved ejection fraction within the current National Health Service model

American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24

Basic Science of Cardiac Contractility Modulation Therapy: Molecular and Electrophysiological Mechanisms

Corvia atrial shunt system: Mean LA pressure reduction device in HFpEF

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC)

Heartfelt innovations: advances in cardiorenal care

What Cardiometabolic Clinicians Can Be Thankful For This Year

Stay Connected